|
Eli Lilly & Company
|
639 South Delaware Street
Indianapolis, IN 46225-1392
United States |
| Tel: |
1/317 276-2000 |
| URL: |
http://www.lilly.com |
|
 |
| Primary Symbols & Exchanges: |
| LLY - New York Stock Exchange |
|
|
| Primary Industry: |
| Pharmaceutical |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activities are to discover, develop, manufacture and market pharmaceutical-based health care solutions. The pharmaceutical products focuses on Neuroscience, Endocrine, Anti-infective, Cardiovascular agents, Oncology and Animal Health. It specializes in research and development, production and marketing of products for the treatment of diabetes worldwide, such as insulin and insulin delivery devices. The Group's pharmaceutical products are distributed through wholesalers. The Group's patents include Zyprexa, Prozac, Permax, Darvon, Humulin, Evista, Humalog, Actos, Humatrope, Ceclor, Vancocin, Keflex, Nebcin , Lorabid, Gemzar, Tylan, Rumensin, Micotil, Surmax, Coban, ReoPro, Xigris, Dobutrex and Axid. The Group operates in the United States, Western Europe and other foreign countries. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Eli Lilly & Company
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
